Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
275 result(s)
Ellipta inhaler products | GSKpro
27-11-2015
Ellipta inhaler information for UK healthcare professionals including getting started, how to use the Ellipta inhaler and top tips for your patients.
GSKpro for UK healthcare professionals
A portal for UK healthcare professionals containing GSK product information, patient resources, exclusive webinars and more
Ordering and delivery
Find out how to set up an account and start ordering GSK vaccines.
GSK support for healthcare professionals in response to COVID-19
Information for healthcare professionals on GSK’s response to COVID-19, where to find support and relevant resources.
Head-to-head data | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) head-to-head data to support UK healthcare professionals
Guidelines | Anoro▼ Ellipta (umeclidinium / vilanterol)
COPD guidelines information relevant to Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals
Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) information to support UK healthcare professionals
vs. LAMA | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA head-to-head data to support UK healthcare professionals
vs. LAMA/LABA | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA/LABA head-to-head data to support UK healthcare professionals
Anoro Patient | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) patient profile information intended to support UK healthcare professionals
Molecules | Anoro▼ Ellipta (umeclidinium / vilanterol)
Information about the molecules in Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals
Webinars & events | GSKpro
A collection of promotional events and webinars featuring experts for UK healthcare professionals
Ellipta critical error studies in COPD
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients
Efficacy
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
BLENREP▼
belantamab mafodotin<br> Oncology
Safety | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Patient Profiles | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Report a possible side effect | GSKpro
Information for UK healthcare professionals on how to report an adverse event related to a GSK product
Contact | GSKpro UK
GSK UK contact page for healthcare professionals.
Dosing & Device | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) dosing & device information to support UK healthcare professionals
Safety | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals
Cost | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals
Coming soon | GSKpro
This page is under construction. If you require assistance, please connect with our Customer Support team via live chat or request to be contacted by a suitable GSK contact.
Request a contact
Contact us form for UK healthcare professionals to contact GSK
Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
PHN-Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
FAQ | Supply | GSKpro
Frequently asked questions around the supply and availability of GSK medicines and vaccines.
Home | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Scientific Rationale | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Respiratory
Overview of COPD and severe asthma.
ZEJULA▼
niraparib<br>Oncology
Experts’ perspectives | Anoro▼ Ellipta (umeclidinium / vilanterol)
Experts' perspectives and patient case study videos relevant to the LAMA/LABA class to support UK healthcare professionals
Guidelines |Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)| GSKPro
Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals
DECTOVA▼
zanamivir IV</br> Influenza
XEVUDY ▼ (sotrovimab)
XEVUDY▼ (sotrovimab) label information for patients and healthcare professionals in Great Britain, including summary of product characteristics and patient information leaflet.
XEVUDY ▼ (sotrovimab)
XEVUDY▼ (sotrovimab) label information for patients and healthcare professionals in Northern Ireland, including summary of product characteristics and patient information leaflet.
Optimising the Paediatric Severe Asthma Journey Webinar Recording
Optimising the Paediatric Severe Asthma Journey Webinar Recording
Cost | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) price information to support UK Healthcare Professionals
Identifying Patients | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Lung Function | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals
HRQoL | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals
Therapy areas | GSKpro UK
Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.
Therapy areas | GSKpro UK
Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.
Molecules | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
BLENREP▼ (belantamab mafodotin)
BLENREP▼ (belantamab mafodotin) product information for healthcare professionals detailing the efficacy, safety and dosing data
Nucala (mepolizumab)
See the safety profile and efficacy data for Nucala (mepolizumab) to support UK Healthcare Professionals.
Efficacy | Nucala (mepolizumab)
See the efficacy data for Nucala (mepolizumab) to support UK Healthcare Professionals.
Resources | Nucala (mepolizumab)
For UK Healthcare Professionals - view resources to support you and your patients using Nucala (mepolizumab).
Nucala (mepolizumab)
Nucala (mepolizumab) information to support UK healthcare professionals.
Dosing & Administration | Nucala (mepolizumab)
Read more about the dosing and administration of Nucala (mepolizumab) to support UK Healthcare Professionals.
Expert Perspectives | Nucala (mepolizumab)
For UK Healthcare Professionals - see what the experts have to say about Nucala (mepolizumab).
Safety Information | Nucala (mepolizumab)
See the safety profile of Nucala (mepolizumab) to support UK Healthcare Professionals.
Exacerbations| Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Video Testimonials: I've Seen Meningitis
Video testimonials from healthcare professionals about the impact of meningitis
XEVUDY ▼ (for GB HCPs)
sotrovimab <br>COVID-19 therapeutics
JEMPERLI ▼
dostarlimab<br>Oncology
Products | GSKpro
GSK product information for UK healthcare professionals
Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Real world evidence | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Invasive Meningococcal Disease I Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Safety | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Vaccinate with SHINGRIX | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Dose & Device| Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) dosing and device information to support UK Healthcare Professionals
Sustainability | GSKpro
Information for UK healthcare professionals on GSK’s carbon neutral inhaler and strategy.
Vaccines
GSK UK information about our vaccines and disease awareness campaigns
Real world evidence
Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) data from real world evidence studies to support UK Healthcare Professionals
Oncology | GSKpro
Oncology at GSK covers a range of therapy areas including ovarian cancer and multiple myeloma. Explore the Oncology GSK resources available to support your appropriate cancer patients.
Safety in PRIMA | ZEJULA ▼ (niraparib)
The safety profile and adverse events of ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Resources | ZEJULA ▼ (niraparib)
Resources for UK healthcare professionals | This website contains promotional information about ZEJULA ▼ (niraparib) and is for UK healthcare professionals only.
Efficacy in the PRIMA trial | ZEJULA ▼ (niraparib)
The efficacy data for ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Mechanism of action | ZEJULA ▼ (niraparib)
Overview of the mechanism of action for ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Dosing in PRIMA | ZEJULA ▼ (niraparib)
Recommended dosing for ZEJULA ▼ (niraparib) and dosing in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
HCP resources | ZEJULA ▼ (niraparib)
Expert lead video content, congress highlights and downloadable resources for healthcare professionals | This website contains promotional information about ZEJULA ▼ (niraparib) and is for UK healthcare professionals only
Patient support for healthcare professionals | ZEJULA ▼ (niraparib)
Resources for healthcare professionals to support patients who have been prescribed ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Patient support & Resources | Seretide (salmeterol/fluticasone propionate)
Seretide (salmeterol/fluticasone propionate) patient support and resources for UK healthcare professionals
Home | Seretide (Salmeterol/fluticasone propionate)
Seretide (Salmeterol/fluticasone propionate) information to support UK health professionals.
ZEJULA ▼ (niraparib)
Overview of ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Efficacy & safety data | Seretide (salmeterol/fluticasone propionate)
Seretide (salmeterol/fluticasone propionate) efficacy & safety data for UK healthcare professionals
Discontinued products | GSK Pro
Discontinued products
Dosing and administration | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Seretide (salmeterol/fluticasone propionate) vs. other ICS/LABAs
Information about the comparison between Seretide (salmeterol/fluticasone propionate) and other ICS/LABAs for UK healthcare professionals
Safety Information | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Home | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Quality of life in PRIMA | ZEJULA ▼ (niraparib)
Quality of life data about ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Medicines management and optimisation
For UK healthcare professionals Access bespoke financial and prescribing data for your health economy. Identify variability, track and optimise your implementation projects
Supply
Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability
Resources | GSKpro
Support your patients and practice with these healthcare resources, ranging from training devices to patient support information.
Identifying Patients | Nucala (mepolizumab)
Identify which patients are suitable for treatment with Nucala (mepolizumab) to support UK Healthcare Professionals.
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
